EVP, General Counsel, Corp Sec
Sat, Mar 14, 2026
Mar 14
exercised or converted securities in ANIK
9,388 shares @ $0.00
Decreased holdings by -33.30%
Net across this filing: +27.30% (+14,470 shares)
ANIKAnika Therapeutics, Inc.
HealthcareDrug Manufacturers - Specialty & Generic
1D0.00%
1W+1.44%
1M+45.69%
3M+46.27%
6M—
1Y—